Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity

The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolati...

Full description

Bibliographic Details
Main Authors: Li, D, Brackenridge, S, Walters, L, Harlos, K, Rozbesky, D, Quastel, M, Borrow, P, Jones, EY, Gillespie, G, McMichael, A
Format: Journal article
Language:English
Published: Springer Nature 2022
_version_ 1797106974046814208
author Li, D
Brackenridge, S
Walters, L
Harlos, K
Rozbesky, D
Quastel, M
Borrow, P
Jones, EY
Gillespie, G
McMichael, A
author_facet Li, D
Brackenridge, S
Walters, L
Harlos, K
Rozbesky, D
Quastel, M
Borrow, P
Jones, EY
Gillespie, G
McMichael, A
author_sort Li, D
collection OXFORD
description The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+ NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.
first_indexed 2024-03-07T07:08:33Z
format Journal article
id oxford-uuid:f1d29120-a307-4036-a147-673b04384f10
institution University of Oxford
language English
last_indexed 2024-03-07T07:08:33Z
publishDate 2022
publisher Springer Nature
record_format dspace
spelling oxford-uuid:f1d29120-a307-4036-a147-673b04384f102022-05-24T14:22:00ZMouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f1d29120-a307-4036-a147-673b04384f10EnglishSymplectic ElementsSpringer Nature2022Li, DBrackenridge, SWalters, LHarlos, KRozbesky, DQuastel, MBorrow, PJones, EYGillespie, GMcMichael, AThe non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+ NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.
spellingShingle Li, D
Brackenridge, S
Walters, L
Harlos, K
Rozbesky, D
Quastel, M
Borrow, P
Jones, EY
Gillespie, G
McMichael, A
Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title_full Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title_fullStr Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title_full_unstemmed Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title_short Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
title_sort mouse and human antibodies bind hla e leader peptide complexes and enhance nk cell cytotoxicity
work_keys_str_mv AT lid mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT brackenridges mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT waltersl mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT harlosk mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT rozbeskyd mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT quastelm mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT borrowp mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT jonesey mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT gillespieg mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity
AT mcmichaela mouseandhumanantibodiesbindhlaeleaderpeptidecomplexesandenhancenkcellcytotoxicity